发明公开
EP2208999A3 Serum bactericidal assay for N. meningitidis specific antisera
有权
对于脑膜炎奈瑟氏球菌特异性抗血清的杀菌血清试验
- 专利标题： Serum bactericidal assay for N. meningitidis specific antisera
- 专利标题（中）： 对于脑膜炎奈瑟氏球菌特异性抗血清的杀菌血清试验
-
申请号： EP10160317.3申请日： 2005-09-05
-
公开(公告)号： EP2208999A3公开(公告)日： 2011-09-21
- 发明人: De Vleeschauwer, Isabel , Durant, Nathalie , Poolman, Jan , Weynants, Vincent
- 申请人： GlaxoSmithKline Biologicals SA
- 申请人地址： Rue de l'Institut 89 1330 Rixensart BE
- 专利权人： GlaxoSmithKline Biologicals SA
- 当前专利权人： GlaxoSmithKline Biologicals SA
- 当前专利权人地址： Rue de l'Institut 89 1330 Rixensart BE
- 代理机构： Johnston, Caroline Louise
- 主分类号： G01N33/569
- IPC分类号： G01N33/569 ; C12N1/22
摘要：
The present invention relates to the field of Serum Bactericidal Activity (SBA) assays for Gram negative bacteria, in particular N. meningitidis. The SBA assay is the most important method for measuring functional activity of scrum antibodies against meningococcus. In order to determine whether a subject or a population is seropositive against invasive meningococcus the SBA test should ideally be both sensitive and specific. The inventors have found the standard N. meningitidis serotype A and W SBAs can be significantly improved in this regard.
公开/授权文献
信息查询
IPC分类:
